Business Description
Brain+ AS
ISIN : DK0061670205
Compare
Compare
Traded in other countries / regions
BRAINP.Denmark0SY.Germany IPO Date
2021-10-07Description
Brain+ AS is a digital therapeutics company. It restores patients' quality of life by treating and detecting a cognitive decline in Alzheimer's disease and dementia through digital means. It has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI).
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.34 | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EPS without NRI Growth Rate | -84.6 | |||||
| 3-Year Book Growth Rate | 20.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64 | |||||
| 9-Day RSI | 56.83 | |||||
| 14-Day RSI | 54.44 | |||||
| 6-1 Month Momentum % | 15.08 | |||||
| 12-1 Month Momentum % | -48.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | |||||
| Quick Ratio | 1.4 | |||||
| Cash Ratio | 1.04 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -54.6 | |||||
| Shareholder Yield % | -67.95 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -133.27 | |||||
| ROA % | -50.94 | |||||
| ROIC % | -33.82 | |||||
| ROC (Joel Greenblatt) % | -7628.2 | |||||
| ROCE % | -48.66 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.3 | |||||
| EV-to-EBIT | -0.83 | |||||
| EV-to-EBITDA | -1.07 | |||||
| EV-to-FCF | -0.94 | |||||
| Earnings Yield (Greenblatt) % | -120.24 | |||||
| FCF Yield % | -65.04 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Brain+ AS Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.278 | ||
| Beta | -0.55 | ||
| Volatility % | 68.96 | ||
| 14-Day RSI | 54.44 | ||
| 14-Day ATR (kr) | 0.007939 | ||
| 20-Day SMA (kr) | 0.09473 | ||
| 12-1 Month Momentum % | -48.02 | ||
| 52-Week Range (kr) | 0.06 - 0.224394 | ||
| Shares Outstanding (Mil) | 212.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Brain+ AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Brain+ AS Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Brain+ AS Frequently Asked Questions
What is Brain+ AS(OCSE:BRAINP)'s stock price today?
The current price of OCSE:BRAINP is kr0.10. The 52 week high of OCSE:BRAINP is kr0.22 and 52 week low is kr0.06.
When is next earnings date of Brain+ AS(OCSE:BRAINP)?
The next earnings date of Brain+ AS(OCSE:BRAINP) is 2025-04-30 Est..
Does Brain+ AS(OCSE:BRAINP) pay dividends? If so, how much?
Brain+ AS(OCSE:BRAINP) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers